3 Profitable Stocks We Find Risky

Yahoo Finance · 2026-08-18

3 Profitable Stocks We Find Risky Petr Huřťák Tue, August 18, 2026 at 6:21 AM EDT 3 min read EHC XOM HII Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn't mean it will thrive tomorrow. A business making money today isn't necessarily a winner, which is why we analyze companies across multiple dimensions at StockStory. That said, here are three profitable companies to steer clear of and a few better alternatives. Trailing 12-Month GAAP Operating Margin: 5.3% Building Nimitz-class aircraft carriers used in active service, Huntington Ingalls (NYSE:HII) develops marine vessels and their mission systems and maintenance services. Annual sales growth of 5.8% over the last two years lagged behind its industrials peers as its large revenue base made it difficult to generate incremental demand Incremental sales over the last five years were much less profitable as its earnings per share fell by 1.9% annually while its revenue grew Free cash flow margin dropped by 5.7 percentage points over the last five years, implying the company became more capital intensive as competition picked up Huntington Ingalls is trading at $318.33 per share, or 17x forward P/E. Dive into our free research report to see why there are better opportunities than HII . Trailing 12-Month GAAP Operating Margin: 18.2% With a network of 161 specialized facilities across 37 states and Puerto Rico, Encompass Health (NYSE:EHC) operates inpatient rehabilitation hospitals that help patients recover from strokes, hip fractures, and other debilitating conditions. Annual revenue growth of 7.4% over the last five years was below our standards for the healthcare sector Weak comparable store sales trends over the past two years suggest there may be few opportunities in its core markets to open new facilities Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 3.5 percentage points At $121.99 per share, Encompass Health trades at 19.4x forward P/E. Read our free research report to see why you should think twice about including EHC in your portfolio, it's free . Trailing 12-Month GAAP Operating Margin: 12.5% One of the successor companies to John D. Rockefeller's Standard Oil monopoly that was broken up in 1911, ExxonMobil (NYSE:XOM) explores for and produces crude oil and natural gas, refines and sells petroleum products, and manufactures petrochemicals. Gross margin of 43.9% reflects its high production costs and unfavorable asset base Costs have risen faster than its revenue over the last five years, causing its EBITDA margin to decline by 1.3 percentage points ExxonMobil's stock price of $161.53 implies a valuation ratio of 13.3x forward P/E. If you're considering XOM for your portfolio, see our FREE research report to learn more . ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time. Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE . Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+214% between June 2020 and June 2025). Find your next big winner with StockStory today .

AI 시장 분석

An analysis has been released on three profitable yet structurally risky stocks: HII, EHC, and XOM. Huntington Ingalls saw earnings per share decline by 1.9% annually due to deepening capital intensity, while Encompass Health experienced a 3.5 percentage point drop in operating margins driven by rising costs. ExxonMobil is also facing pressured EBITDA margins as cost increases outpace revenue growth. Investors must closely examine sustainability and cost structures beyond simple profit generation.

하락 영향

Defense — Huntington Ingalls (HII) lagged behind industrial peers with a 2-year annualized revenue growth rate of 5.8%, saw a 1.9% annual decline in earnings per share, and faces downward pressure due to deepening capital intensity.
Healthcare — Encompass Health (EHC) fell short of criteria with a 5-year annualized revenue growth rate of 7.4%, experienced a 3.5 percentage point drop in adjusted operating margins, and faces major profitability concerns due to rising costs.
Energy — ExxonMobil (XOM) saw its 5-year EBITDA margin decline by 1.3 percentage points as costs grew faster than revenues, with upside potential limited by high production costs and an unfavorable asset base.

DYAX 전담 분석

This analysis warns that major profitable companies such as HII, EHC, and XOM are facing fundamental limitations and cost pressures despite outward appearances. Slowing revenue growth and deepening capital intensity directly translate to future cash flow and downward valuation pressure, which may negatively impact stock prices.

Key watchpoints moving forward are whether these companies can improve margins and achieve cost efficiency metrics. If they fail to control costs and profitability deteriorates further, a bearish trend driven by valuation multiple contraction is expected, whereas a recovery in efficiency through restructuring could open up a rebound scenario.

AI가 생성한 분석으로 투자 자문이 아닙니다.

DYAX Investor Sentiment

Bullish (Long) 34% · Bearish (Short) 66%

309 participants

Related News

원문 보기 — Yahoo Finance